This topic contains a solution. Click here to go to the answer

Author Question: A second-generation H1 receptor antagonist antihistamine formulated as a nasal spray for topical use ... (Read 30 times)

LaDunn

  • Hero Member
  • *****
  • Posts: 526
A second-generation H1 receptor antagonist antihistamine formulated as a nasal spray for topical use is
 
  A) chlorpheniramine (Chlor-Trimeton).
  B) clemastine (Tavist).
  C) cyproheptadine (Periactin).
  D) azelastine (Astelin).

Question 2

A patient is receiving digoxin (Lanoxin) and a potassium supplement. When monitoring daily laboratory values, what should the potassium level be for this patient?
 
  A) 1.53.0 mEq/L
  B) 3.55.0 mEq/L
  C) 5.07.5 mEq/L
  D) 6.06.5 mEq/L



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tennis14576

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

D
Feedback:
Azelastine (Astelin) and olopatadine (Patanol) are second-generation H1 receptor antagonists that have been formulated as nasal sprays for topical use. Each of the other listed drugs is a first-generation H1 receptor antagonist.

Answer to Question 2

B




LaDunn

  • Member
  • Posts: 526
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


adammoses97

  • Member
  • Posts: 337
Reply 3 on: Yesterday
Excellent

 

Did you know?

The most common treatment options for addiction include psychotherapy, support groups, and individual counseling.

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

For a complete list of videos, visit our video library